Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Glaxf crawled time : 13:00 save search
CureVac meldet Fortschritte in klinischen Phase-2-Entwicklungsprogrammen für COVID-19 und die saisonale Grippe in Zusammenarbeit mit GSK
Published: 2023-11-01 (Crawled : 13:00) - curevac.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.62%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -4.06%
H: 1.9%
C: 0.96%
CVAC | $2.44 -5.06% -5.33% 710K
|
Health Technology
|
| O: 0.19%
H: 3.95%
C: -1.32%
covid-19 phase 2
Renal Anemia Therapeutics Market size to grow by USD 1.97 billion from 2021 to 2026, Driven by the presence of a large pool of CKD patients - Technavio
Published: 2023-04-07 (Crawled : 13:00) - prnewswire.com
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
| Email alert
Add to watchlist
AZNCF | $140.15 -4.19% 560
|
Health Technology
| Email alert
Add to watchlist
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
| Email alert
Add to watchlist
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
| Email alert
Add to watchlist
PSORF | $13.01 -8.53% 110
|
Consumer Services
| Email alert
Add to watchlist
GLAXF | $20.2 -14.18% 510
|
Health Technology
| Email alert
Add to watchlist
renal anemia therapeutics market
PFIZER REPORTS RECORD FULL-YEAR 2022 RESULTS AND PROVIDES FULL-YEAR 2023 FINANCIAL GUIDANCE
Published: 2023-01-31 (Crawled : 13:00) - biospace.com/
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 2.04%
H: 0.0%
C: -3.67%
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: -1.26%
H: 2.97%
C: 2.7%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.85%
H: 0.31%
C: -0.45%
BHVN | News 0 d | $42.18 -4.2% 0.0% 3.6M
|
Health Technology
|
| O: -0.48%
H: 4.49%
C: 3.24%
BNTX | $86.19 -0.24% -0.24% 570K
|
Health Technology
|
| O: -1.74%
H: 4.84%
C: 3.88%
BEAM | $24.33 0.08% 0.08% 1.6M
|
Health Technology
|
| O: 0.21%
H: 4.84%
C: 2.99%
financial results
Insights on the Substance Abuse Treatment Global Market to 2030 - by Treatment and Region
Published: 2023-01-30 (Crawled : 13:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -2.59%
H: 3.12%
C: 1.79%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.74%
H: 0.2%
C: -1.24%
ALKS | News | $23.78 -0.96% -0.97% 1.8M
|
Health Technology
|
| O: 0.07%
H: 0.83%
C: -0.86%
treatment global market
The Worldwide Manual Toothbrush Industry is Expected to Reach $8.1 Billion by 2028
Published: 2023-01-17 (Crawled : 13:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.95%
H: 3.65%
C: 3.19%
UNLYF | $47.0 1.3% 460
|
Consumer Non-Durables
|
| O: 1.38%
H: 0.0%
C: 0.0%
UL | $46.84 0.32% 0.0% 5.7M
|
Consumer Non-Durables
|
| O: -0.68%
H: 0.53%
C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.31%
H: 0.62%
C: 0.2%
expected
Outlook on the Pharmaceutical Drugs Global Market to 2027: Look at the Changing Structure of the Pharma and Healthcare Industry
Published: 2023-01-03 (Crawled : 13:00) - prnewswire.com
ENDPQ | $0.0006 -50.0% 620K
|
n/a
|
| O: -1.13%
H: 28.57%
C: 19.0%
CSLLY | $87.96 3.3% 45K
|
n/a
|
| O: -3.93%
H: 2.17%
C: 1.75%
MNK | $0.3402 -0.06% 540K
|
n/a
|
| O: 3.1%
H: 0.0%
C: -2.75%
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.2%
H: 2.06%
C: 2.06%
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 1.09%
H: 0.54%
C: 0.54%
UCBJY | $64.07 -4.38% 72K
|
Manufacturing
|
| O: 1.0%
H: 0.0%
C: -0.26%
ALPMY | News | $9.46 -1.11% 500K
|
Manufacturing
|
| O: 3.43%
H: 0.0%
C: -2.93%
VTRS | $11.11 0.09% 0.09% 3.5M
|
Health Technology
|
| O: 0.54%
H: 2.5%
C: 1.7%
NVO | News | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 1.43%
H: 0.84%
C: -0.23%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.42%
H: 1.35%
C: 1.22%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.28%
H: 1.26%
C: 1.15%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.57%
H: 1.35%
C: 1.0%
BHC | $8.6 -0.69% 0.0% 2.1M
|
Health Technology
|
| O: 0.48%
H: 3.96%
C: -0.48%
ABBV | $164.69 0.27% 0.0% 4.5M
|
Health Technology
|
| O: 0.27%
H: 0.6%
C: 0.21%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.67%
H: 0.66%
C: 0.3%
pharma global market
Consumer Healthcare Global Market Report 2022
Published: 2022-09-20 (Crawled : 13:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -6.97%
H: 7.7%
C: -0.76%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.33%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.71%
H: 0.2%
C: -0.23%
ABT | News | $105.28 -0.59% 0.0% 7.3M
|
Health Technology
|
| O: -1.25%
H: 0.23%
C: -0.47%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -1.18%
H: 0.0%
C: 0.0%
global report market
Human Papillomavirus Vaccine (HPV) Market to Reach $10.8 Bn, Globally, by 2031 at 12.4% CAGR: Allied Market Research
Published: 2022-07-21 (Crawled : 13:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 6.64%
H: 0.0%
C: -4.08%
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -2.38%
H: 0.0%
C: 0.0%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 0.15%
H: 0.0%
C: -3.5%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.09%
H: 1.9%
C: 1.89%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -1.18%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 1.3%
H: 0.38%
C: -0.38%
XBIO | $4.165 7.9% 7.32% 7.9K
|
Health Technology
|
| O: 0.41%
H: 7.44%
C: -2.71%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -3.38%
H: 0.0%
C: 0.0%
INO 2 d | $10.22 -7.68% -8.32% 400K
|
Health Technology
|
| O: 0.0%
H: 1.35%
C: -5.83%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -2.75%
H: 2.31%
C: 2.15%
research vaccine market
Oak Hill Bio Announces Formation of Board of Directors
Published: 2022-04-12 (Crawled : 13:00) - biospace.com/
TAK | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: 0.07%
H: 0.47%
C: -0.4%
NVO | News | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -3.41%
H: 1.22%
C: 0.49%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -3.25%
H: 0.0%
C: 0.0%
ViiV Healthcare to present new long-term findings from its innovative 2-drug and long-acting HIV medicines portfolio at CROI 2022
Published: 2022-02-07 (Crawled : 13:00) - biospace.com/
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: 0.4%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.29%
H: 0.7%
C: 0.49%
health thc drug hiv
Primary endpoint met in COMET-TAIL Phase 3 trial evaluating intramuscular administration of sotrovimab for early treatment of COVID-19
Published: 2021-11-12 (Crawled : 13:00) - biospace.com/
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.8%
H: 0.0%
C: -0.31%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.93%
H: 0.0%
C: 0.0%
VIR | $7.96 -3.52% -3.64% 870K
|
Health Technology
|
| O: 4.66%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.66%
H: 0.0%
C: 0.0%
covid treatment phase 3 trial
PFIZER REPORTS THIRD-QUARTER 2021 RESULTS
Published: 2021-11-02 (Crawled : 13:00) - biospace.com/
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.14%
H: 0.94%
C: -1.98%
ALPMY | News | $9.46 -1.11% 500K
|
Manufacturing
|
| O: -1.58%
H: 0.42%
C: 0.24%
VTRS | $11.11 0.09% 0.09% 3.5M
|
Health Technology
|
| O: 3.46%
H: 0.7%
C: -0.09%
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: 2.06%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 1.16%
H: 0.75%
C: -0.19%
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -1.55%
H: 0.0%
C: 0.0%
BNTX | $86.19 -0.24% -0.24% 570K
|
Health Technology
|
| O: 0.13%
H: 3.09%
C: 2.62%
ARVN | $34.3 2.54% 2.48% 800K
|
Health Technology
|
| O: 1.4%
H: 4.09%
C: 4.07%
results
Alnylam Announces Planned CEO Leadership Transition
Published: 2021-10-28 (Crawled : 13:00) - biospace.com/
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.06%
H: 3.7%
C: 1.85%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 2.23%
H: 2.11%
C: 1.94%
ALNY | $145.045 -0.19% -0.19% 400K
|
Health Technology
|
| O: -11.56%
H: 2.01%
C: -4.1%
ceo leo
Gainers vs Losers
| 66% | 34% |
Top 10 Gainers
AGBA | $1.02 155.0% 60.78% 120M
|
Finance
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 900K
|
OST | $0.499 21.38% 45.26% 1.9M
|
ZCMD | $2.44 78.1% 43.85% 330K
|
Commercial Services
XPON | $3.1 60.62% 37.74% 16M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.